Ultibro Breezhaler

Ultibro Breezhaler Description

indacaterol + glycopyrronium

Manufacturer:

Novartis

Distributor:

Zuellig Pharma

Marketer:

A. Menarini
Full Prescribing Info
Description
Each capsule contains 143 micrograms of indacaterol maleate equivalent to 110 micrograms of indacaterol and 63 micrograms of glycopyrronium bromide equivalent to 50 micrograms of glycopyrronium.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 110 micrograms of indacaterol maleate equivalent to 85 micrograms of indacaterol and 54 micrograms of glycopyrronium bromide equivalent to 43 micrograms of glycopyrronium.
Excipient(s) with known effect: Each capsule contains 23.5 mg lactose (as monohydrate).
Excipients/Inactive Ingredients: Capsule fill: Lactose monohydrate, Magnesium stearate.
Capsule shell components: Hypromellose, purified water, carrageenan, potassium chloride, FD&C Yellow5/Tartrazine.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in